Find out how clinical trial sponsors are preparing to follow the new FDA guidance on diversity action plans and how technology solutions can support this effort. Our 2024 report into the State of Diversity and Equity in Clinical Trials identifies the latest developments and strategic insights that are critical for enhancing clinical trial diversity. Download here: https://hubs.la/Q02S24L10 #healthequity #clinicaltrialdiversity #patientrepresentation #diversityinclusion
H1
Software Development
New York, NY 17,524 followers
H1 is the connecting force for global HCP, clinical, scientific and research information.
About us
At H1, our mission is nothing short of creating a healthier future worldwide by unlocking and democratizing global access to critical expertise, HCP information, claims data, ground-breaking research and discoveries, and connected insights for all – doctors, researchers, industry and, ultimately, patients – bringing everyone closer together to advance medicine and clinical outcomes. Insights derived from H1’s solutions help life sciences and other healthcare organizations accelerate the development, launch, and dissemination of life-saving treatments, drive meaningful engagements with key opinion leaders, and help ensure equitable access to healthcare services.
- Website
-
https://h1.co
External link for H1
- Industry
- Software Development
- Company size
- 201-500 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 2017
- Specialties
- healthcare, provider data, healthcare professional information, diversity data, medical affairs, pharmaceutical, data science, medical science liaison, msl education, key opinion leaders, kol mapping, biotechnology, life sciences, healthcare data, HCPs, SaaS, healthcare content, clinical trials, clinical operations, and global drug development
Locations
-
Primary
373 Park Ave S
4th Floor
New York, NY 10016, US
Employees at H1
Updates
-
In times of crisis, mobilizing resources efficiently can be the difference between life and death. Technology offers a powerful tool to cut through the red tape to focus on what truly matters—saving lives. In his new article for Forbes Technology Council, our CEO Ariel Katz highlights how harnessing innovative technologies can be pivotal to transcending the limitations of politics and policy during times of need. Read more here: https://hubs.la/Q02RTswm0 #HumanitarianEfforts #MedicalAid
-
Will you be attending The MedTech Conference in a couple of weeks? H1’s Chris Gardella, SVP Commercial and Kyle Horton, Account Executive will be at #MTC24 to support medical device companies as they prepare to meet FDA guidance on Diversity Action Plans. Would it benefit you to see how other med device companies are using H1 to support FDA diversity planning? Connect with Chris and Kyle to see how H1 empowers medical device sponsors to find diverse sites and patients for more equitable clinical trials. Hope to see you there! https://hubs.la/Q02RJlfQ0 #medtech #healthequity #clinicaltrialdiversity #equitablecare #healthcareinnovation
-
While many eyes have been focused on the FDA's latest draft guidance for Diversity Action Plans, global diversity regulations are also evolving. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is set to release new diversity and inclusion guidelines later this year to improve care for underserved populations. Improving clinical trial representation depends on finding the right trial sites for your studies. H1 offers diversity insights in England that inform and strengthen equitable clinical trial planning. Learn more about how Trial Landscape can support global efforts to build more diverse clinical trials: https://hubs.la/Q02Rx_Yq0 Request a demo here: https://hubs.la/Q02RyclN0 #diversityinclusion #d&i #clinicaltrialdiversity #healthequity #patientdiversity
-
Later this week, the 2024 Innovation Network Gathering will ask participants to identify the biggest barriers to designing more human-centric clinical trials and to begin developing solutions to help shape a more patient-centered future. H1’s Ryan B., Regional VP of Sales, will be attending to help solve the most pressing challenges of clinical trials and to explore the potential impact of new technologies like AI on clinical research. Learn more: https://hubs.la/Q02Rjtcq0 #innovationnetworkgathering #humancentrictrials #clinicaltrialdiversity #healthequity #healthcareinnovation
-
We appreciate the excellent turnout for this morning's panel at #FierceClinicalSummit about “Paving the Way for Innovation.” Our CEO & Co-founder Ariel Katz joined an incredible group of experts for a thoughtful conversation about novel strategies that are impacting clinical efficiency and quality. The H1 team will be at booth 6 for the remainder of the conference if you have follow-up questions or would like to see our solutions in action. Hope to speak with you! #healthcareinnovation #clinicaltrials #ai #clinicalinsights
-
UCB is celebrating 3 FDA approvals this week for its IL-17A and IL-17F inhibitor drug Bimzelx. UCB states that it is now the only treatment of its kind to be approved in the U.S. for four chronic immune-mediated inflammatory diseases. The approvals came following four phase 3 trials that showed the drug delivered better results when compared to placebo in improving symptoms of the inflammatory diseases. Learn more: https://hubs.la/Q02QWvtJ0 #ucb #bimzelx #inflammatorydisease
UCB adds three more FDA approvals to label for potential blockbuster Bimzelx
endpts.com
-
Thanks to everyone who attended today’s panel at Fierce #MASSWest: “Leveraging Technology and Innovative Tools for Enhanced MSL Effectiveness.” H1’s Robert Consalvo, Sr. Director of Strategic Commercial Engagement, had the pleasure of joining in today’s discussion. Remember you can visit our team in booth 13 for the remainder of the conference. We’re happy to demo our solutions and answer any questions you may have. #fiercemasswest #medicalaffairs #msls #hcpengagement
-
We’re excited to be at #FierceClinicalSummit today! It’s wonderful to see everyone at this year’s event. If you’re attending the show, we invite you to stop by booth 6 to see how our clinical trial intelligence can support your goals of running successful and equitable clinical trials. #clinicaltrialdiversity #sitefeasibility #siteselection #healthequity
-
Are you at Fierce #MASSWest this week? It should be an excellent couple of days for medical teams to explore solutions for improving HCP engagement strategies, product launch planning and more. H1 can help with KOL mapping, HCP outreach, measuring #medicalaffairs impact and more, powered by AI technology. Find us in booth 13 today and tomorrow to see our solutions in action!